Metropolis Healthcare Limited informed that Mr. Milind Sarwate (DIN: 00109854) has completed his term of 5 (five) years as an Independent Director of the Company on September 06, 2023. Consequently, he ceased to be a Director of the Company and Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee with effect from the closure of business hours on September 06, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,805 INR | +1.89% | +3.76% | +7.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.56% | 1.11B | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
-15.34% | 1.03B | |
-16.56% | 878M |
- Stock Market
- Equities
- METROPOLIS Stock
- News Metropolis Healthcare Limited
- Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023